Home >> Research Area >>Metabolism>>ALP>> (-)-p-Bromotetramisole Oxalate

(-)-p-Bromotetramisole Oxalate

ALP inhibitor, potent and non-specific CAS# 62284-79-1

(-)-p-Bromotetramisole Oxalate

Catalog No. BCC5449----Order now to get a substantial discount!

Product Name & Size Price Stock
(-)-p-Bromotetramisole Oxalate: 5mg $35 In Stock
(-)-p-Bromotetramisole Oxalate: 10mg Please Inquire In Stock
(-)-p-Bromotetramisole Oxalate: 20mg Please Inquire Please Inquire
(-)-p-Bromotetramisole Oxalate: 50mg Please Inquire Please Inquire
(-)-p-Bromotetramisole Oxalate: 100mg Please Inquire Please Inquire
(-)-p-Bromotetramisole Oxalate: 200mg Please Inquire Please Inquire
(-)-p-Bromotetramisole Oxalate: 500mg Please Inquire Please Inquire
(-)-p-Bromotetramisole Oxalate: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of (-)-p-Bromotetramisole Oxalate

Number of papers citing our products

Chemical structure

(-)-p-Bromotetramisole Oxalate

3D structure

Chemical Properties of (-)-p-Bromotetramisole Oxalate

Cas No. 62284-79-1 SDF Download SDF
PubChem ID 112477 Appearance Powder
Formula C13H13BrN2O4S M.Wt 373.22
Type of Compound N/A Storage Desiccate at -20°C
Synonyms L-p-Bromotetramisole oxalate; 6-Bromolevamisole oxalate; (-)-p-Bromolevamisole oxalate
Solubility DMSO : ≥ 29 mg/mL (77.70 mM)
*"≥" means soluble, but saturation unknown.
Chemical Name 6-(4-bromophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole;oxalic acid
SMILES C1CSC2=NC(CN21)C3=CC=C(C=C3)Br.C(=O)(C(=O)O)O
Standard InChIKey ZULBIBHDIQCNIS-UHFFFAOYSA-N
Standard InChI InChI=1S/C11H11BrN2S.C2H2O4/c12-9-3-1-8(2-4-9)10-7-14-5-6-15-11(14)13-10;3-1(4)2(5)6/h1-4,10H,5-7H2;(H,3,4)(H,5,6)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of (-)-p-Bromotetramisole Oxalate

Description(-)-p-Bromotetramisole Oxalate is a potent and non-specific inhibitor of alkaline phosphatase.
Targetsalkaline phosphatase    

(-)-p-Bromotetramisole Oxalate Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

(-)-p-Bromotetramisole Oxalate Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of (-)-p-Bromotetramisole Oxalate

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.6794 mL 13.3969 mL 26.7938 mL 53.5877 mL 66.9846 mL
5 mM 0.5359 mL 2.6794 mL 5.3588 mL 10.7175 mL 13.3969 mL
10 mM 0.2679 mL 1.3397 mL 2.6794 mL 5.3588 mL 6.6985 mL
50 mM 0.0536 mL 0.2679 mL 0.5359 mL 1.0718 mL 1.3397 mL
100 mM 0.0268 mL 0.134 mL 0.2679 mL 0.5359 mL 0.6698 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on (-)-p-Bromotetramisole Oxalate

(-)-p-Bromotetramisole Oxalate (L-(-)-p-Bromotetramisole Oxalate, L-p-Bromotetramisole Oxalate, (-)-4-Bromotetramisole Oxalate) is a potent and non-specific inhibitor of alkaline phosphatase and is also an inhibitor of protein tyrosine phosphatases [1] [2].

Alkaline phosphatase is a hydrolase enzyme that removes phosphate groups from nucleotides, proteins and alkaloids. Protein tyrosine phosphatase is an enzyme that removes phosphate groups from phosphorylated tyrosine residues on target proteins.

(-)-p-Bromotetramisole Oxalate is an inhibitor of alkaline phosphatase and protein tyrosine phosphatases. In various rat tissues, (-)-p-Bromotetramisole Oxalate (0.1 μM) completely inhibited non-specific alkaline phosphatase [1]. In rat zona glomerulosa, (-)-p-Bromotetramisole Oxalate (100 μM) blocked the inhibition of Na+ pump (Na+, K+-ATPase) induced by angiotensin II. The result suggested that inhibition of the Na+ pump induced by angiotensin II might be mediated by a tyrosine phosphatase [2]. In neurosecretory PC12 cells, (-)-p-Bromotetramisole Oxalate (0.3 mM) increased ionomycin-stimulated noradrenaline (NA) release, which suggested that tyrosine phosphorylation regulated Ca2+-stimulated NA release [3].

In Sprague-Dawley rats, (-)-p-Bromotetramisole Oxalate (10 μM) significantly increased fractional excretion of phosphate (FEPi) from 4.7% to 13.4% [4].

References:
[1].  Borgers M, Thoné F. The inhibition of alkaline phosphatase by L-p-bromotetramisole. Histochemistry, 1975, 44(3): 277-280.
[2].  Yingst DR, Davis J, Schiebinger R. Inhibitors of tyrosine phosphatases block angiotensin II inhibition of Na(+) pump. Eur J Pharmacol, 2000, 406(1): 49-52.
[3].  Kitamura T, Murayama T, Nomura Y. Enhancement of Ca2+-induced noradrenaline release by vanadate in PC12 cells: possible involvement of tyrosine phosphorylation. Brain Res, 2000, 854(1-2): 165-171.
[4].  Onsgard-Meyer M, McCoy AL, Knox FG. Effect of bromotetramisole on renal phosphate excretion. Proc Soc Exp Biol Med, 1996, 213(2): 193-195.

Featured Products
New Products
 

Description

(-)-p-Bromotetramisole Oxalate is a potent and non-specific alkaline phosphatase inhibitor.

Keywords:

(-)-p-Bromotetramisole Oxalate,62284-79-1,L-p-Bromotetramisole oxalate; 6-Bromolevamisole oxalate; (-)-p-Bromolevamisole oxalate,Natural Products,ALP, buy (-)-p-Bromotetramisole Oxalate , (-)-p-Bromotetramisole Oxalate supplier , purchase (-)-p-Bromotetramisole Oxalate , (-)-p-Bromotetramisole Oxalate cost , (-)-p-Bromotetramisole Oxalate manufacturer , order (-)-p-Bromotetramisole Oxalate , high purity (-)-p-Bromotetramisole Oxalate

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: